Generic Aadhaar

Thane, India Founded: 2018 • Age: 8 yrs Minicorn
Manufacturer of generic drugs

About Generic Aadhaar

Generic Aadhaar is a Healthcare company based in Thane (India) founded in 2018 by Arjun Deshpande. Manufacturer of generic drugs. Generic Aadhaar has raised $1.97 million across 2 funding rounds from investors including Beyond Next Ventures and Ratan N Tata. Generic Aadhaar was last valued at $15.69 million in May 2022. Its chief executive, as recorded, is Arjun Deshpande. Its website genericaadhaar.com draws about 63 thousand monthly visits. Its Indian entity Swasthya Lifescience Private Limited reported revenue of β‚Ή24.57 Cr. Generic Aadhaar offers products and services including Generic Medicines and Pharmacy Franchises. Its focus areas include Pharmacies and Pharmaceutical Drugs.

Company details

Generic Aadhaar was founded in 2018 in Thane, India, within the pharmaceuticals sector. Operations focus on producing and distributing generic drugs, with direct sales to end-users facilitated through a mobile application for home delivery. Franchise opportunities for standalone pharmacies are supported to enable competition with larger retail chains and online platforms across India.

  • Headquarters Thane, India
  • Founders Arjun Deshpande
  • Stage Minicorn
  • Sectors
    Healthcare
  • Website category Finance · Investing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website genericaadhaar.com
  • Social LinkedIn Facebook Instagram
  • Legal Name Swasthya Lifescience Private Limited
  • Date of Incorporation 24 Feb, 2020
  • Jurisdiction Kalwa, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹24.57 Cr

    FY 2025 · +26% YoY

  • Net Profit
    ₹1.49 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹2.15 Cr

    FY 2025 · 9% margin

  • Total Equity Funding
    $1.97M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.96M (USD), Seed

    May 2022

  • Investors

Products & Services of Generic Aadhaar

Generic Aadhaar offers a comprehensive portfolio of products and services, including Generic Medicines and Pharmacy Franchises.

Generic Medicines
Pharmaceutical Products

Affordable generic drugs are supplied for daily use, addressing high medicine prices in the market.

Pharmacy Franchises
Business Services

Franchise opportunities are offered to empower medical store owners and entrepreneurs with branding and support.

Funding Insights of Generic Aadhaar

Generic Aadhaar has successfully raised a total of $1.97M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.96 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.97M
  • Total Rounds 2
  • Last Round Seed β€” $1.96M
  • First Round $13,280

    (May 2020)

  • Investors Count 2

All 2 funding rounds of Generic Aadhaar with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$1.96MSeed$15.69MBeyond Next Ventures
–
May 2020$13,280Angel Round$195,578Ratan N Tata
–
Valuation history
DateValuationStage
May 2022$15.69Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $15.69M (May 2022). 2 investors in total: 1 institutional and 1 angel.

Investors in Generic Aadhaar

Generic Aadhaar has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Beyond Next Ventures and Ratan N Tata.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
2014beyondnextventures.comTokyo, Japan

Ratan N Tata

Chairman Emeritus of Tata Sons, iconic industrialist, and active angel investor
unknown_e1a9d6c95ff94f5f9
Premium access

Investor details for Generic Aadhaar

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Swasthya Lifescience Private Limited (Generic Aadhaar)

Swasthya Lifescience Private Limited is the primary company behind Generic Aadhaar. The board of Swasthya Lifescience Private Limited currently have 2 directors; the longest-serving is Aarti Rajesh Deshpande, appointed in 2020. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Aarti Rajesh Deshpande
DIN 07737832
Director06 May 20206 yrs 6 moSwasthya Lifescience Private Limited
Arjun Rajesh Deshpande
DIN 08746367
Director23 May 20206 yrs 5 moSwasthya Lifescience Private Limited

People of Generic Aadhaar

1 people are tracked at Generic Aadhaar (1 in leadership).

NameRoleGroup
Founder & CEOLeadership
Premium access

Complete people profiles for Generic Aadhaar

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Generic Aadhaar

Figures of Swasthya Lifescience Private Limited, the primary company behind Generic Aadhaar, for FY 2025. Revenue was ₹24.57 Cr (+26% year on year). Net profit was ₹1.49 Cr (6% margin). EBITDA was ₹2.15 Cr (9% margin). Revenue has grown at a compounded annual rate of +41% over three years and +504% over five years.

  • ₹24.57 CrRevenue · FY 2025 · +26% YoY
  • ₹1.49 CrNet profit · 6% margin
  • ₹2.15 CrEBITDA · 9% margin
  • ₹1.2 LakhPaid-up capital
  • +41%Revenue CAGR, 3 years
  • +504%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Swasthya Lifescience Private Limited are on its company page.

Premium access

Detailed financial statements for Generic Aadhaar

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Generic Aadhaar

4 dated milestones of Generic Aadhaar across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Generic Aadhaar is founded.
  2. Funding First funding round of $13K.
  3. Funding Latest funding round, Seed, of $2.0M.
  4. Milestone Reaches Minicorn status.

Web traffic of Generic Aadhaar

The website of Generic Aadhaar (genericaadhaar.com) receives about 62.7K visits a month and ranks #325,230 among all websites worldwide, #3,421 in Investing.

  • Monthly visits
    62.7K

    ▼ 23.6% vs previous month

  • Unique visitors
    25.4K

    per month

  • Global rank
    #325,230

    among all websites

  • Category rank
    #3,421

    Finance · Investing

Similar websites

Websites whose visitors overlap most with Generic Aadhaar. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
wellnessforever.com
100%
480.8K#74,529View details
davaindia.com
82%
121K#262,189View details
medibuddy.in
60%
1.4M#38,660View details
universalsompo.com
60%
227.5K#202,321View details
vvcmc.in
60%
#306,120View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for Generic Aadhaar

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Generic Aadhaar

Generic Aadhaar was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Generic Aadhaar is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.

Arjun Deshpande is the CEO of Generic Aadhaar, as recorded in our data. They have also founded this company.

Generic Aadhaar is a funded company, having raised a total of $1.97M across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $13.28K, raised on May 2020.

The primary company behind Generic Aadhaar, Swasthya Lifescience Private Limited, reported revenue of β‚Ή24.57 Cr for FY 2025, up 26% year on year.

Generic Aadhaar was founded in 2018 in Thane, India, within the pharmaceuticals sector. Operations focus on producing and distributing generic drugs, with direct sales to end-users facilitated through a mobile application for home delivery. Franchise opportunities for standalone pharmacies are supported to enable competition with larger retail chains and online platforms across India.

Generic Aadhaar offers Generic Medicines and Pharmacy Franchises.

Generic Aadhaar has 2 investors. Key investors include Beyond Next Ventures, and Ratan N Tata.

The valuation of Generic Aadhaar is $15.69M as of May 2022.

Generic Aadhaar operates through Swasthya Lifescience Private Limited.

The legal entities of Generic Aadhaar currently have 2 directors, including Arjun Rajesh Deshpande, Aarti Rajesh Deshpande.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available